Optimizing Hand Rehabilitation Post-Stroke Using Interactive Virtual Environments
Launched by NEW JERSEY INSTITUTE OF TECHNOLOGY · Feb 19, 2010
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
The complexity of sensorimotor control required for hand function as well as the wide range of recovery of manipulative abilities makes rehabilitation of the hand most challenging. The investigators past work has shown that training in a virtual environment (VE) using repetitive, adaptive algorithms has the potential to be an effective rehabilitation medium to facilitate motor recovery of hand function. These findings are in accordance with current neuroscience literature in animals and motor control literature in humans. The investigators are now in a position to refine and optimize elemen...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Six months post cerebrovascular accident
- • Residual upper extremity impairment that affects participation
- • At least ten degrees of active finger extension
- • Tolerate passive shoulder flexion to chest level
- Exclusion Criteria:
- • Severe neglect
- • Severe aphasia
About New Jersey Institute Of Technology
The New Jersey Institute of Technology (NJIT) is a leading research university dedicated to advancing innovation and technology in various fields, including healthcare. As a clinical trial sponsor, NJIT leverages its robust academic resources and interdisciplinary expertise to conduct cutting-edge research aimed at improving patient outcomes and advancing medical knowledge. With a commitment to ethical standards and regulatory compliance, NJIT collaborates with healthcare professionals, industry partners, and regulatory agencies to facilitate rigorous clinical trials that contribute to the development of novel therapies and interventions. Through its initiatives, NJIT aims to enhance public health and drive scientific discovery in the biomedical sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, New Jersey, United States
Patients applied
Trial Officials
Sergei V. Adamovich, PhD
Principal Investigator
New Jersey Institute of Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials